OncoSphere AI gives every oncologist a multidisciplinary tumor board on demand — eight specialist AI agents that turn a patient case into an evidence-tied, guideline-anchored MDT recommendation in minutes. OncoSphere AI is clinical decision support — advisory by design. It never replaces your tumor board and never makes the decision; it synthesizes the case so the physician can decide faster, with the evidence in front of them.
What it does
Oncology decision-making is bottlenecked by the work of synthesizing fragmented records across specialties. OncoSphere AI automates that "perception layer." Eight virtual specialty agents — Medical Oncology, Radiation Oncology, Surgical Oncology, Pathology, Radiology, Pharmacy, Clinical Research, and Nurse Navigation — independently analyze a patient's structured and unstructured data against specialty-specific guidelines and contemporary peer-reviewed literature, then assemble a single, guideline-anchored MDT recommendation.
Validated in a study presented at ASCO 2026
Source: Desai A, McNeeley E, Alhushki S, et al. OncoSphere AI: An agentic AI multidisciplinary clinical workflow support tool. J Clin Oncol. 2026;44(16_suppl):e13656. View abstract →
Why OncoSphere AI
Eight specialists, one consensus
A coordinated ensemble of domain-specialized agents — not a single generic chatbot — each reasoning against its own guidelines and the latest literature.
Evidence-tied by design
Every recommendation is anchored to guidelines and peer-reviewed literature, with citations surfaced for the physician to verify.
Minutes, not half an hour
In validation, OncoSphere AI averaged 4.7 minutes per case versus 29.3 minutes for manual review.
Coding & charge-capture support
Bundled ICD-10 / CPT coding assistance and charge-capture support help community practices document and bill accurately.
Built for trust
HIPAA-aligned, with a signed BAA in place with Google Cloud. PHI handling and citation traceability are core to the design.
Advisory, always
OncoSphere AI is clinical decision support. The physician always decides; the platform informs the decision.
Who it's for
Community oncology practices and health systems that want the rigor of a multidisciplinary tumor board on every case — without waiting for the weekly conference. See how practices use OncoSphere AI →